News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
36 Results
Type
Article (8)
Press Release (28)
Section
Business (11)
Deals (1)
Drug Development (8)
News (19)
Tag
Alliances (1)
Clinical research (10)
Collaboration (1)
Data (3)
Earnings (3)
Events (1)
FDA (1)
Funding (1)
Medical device (3)
Medtech (3)
Mergers & acquisitions (4)
NextGen: Class of 2026 (2)
People (7)
Phase 1 (5)
Phase 2 (5)
Phase 3 (2)
Pipeline (2)
Regulatory (1)
Date
Last 7 days (1)
Last 30 days (1)
Last 365 days (10)
2026 (1)
2025 (9)
2022 (3)
2021 (2)
2020 (3)
2019 (3)
2018 (1)
2017 (6)
2016 (7)
2015 (1)
Location
Asia (13)
California (1)
Europe (4)
India (1)
Massachusetts (9)
Southern California (1)
United States (10)
36 Results for "vyome".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vyome Successfully Capitalizes All VT-1953 Funding Requirements For Initial Phase 3 Results
February 2, 2026
·
4 min read
Press Releases
Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing
November 19, 2025
·
7 min read
Press Releases
Vyome Reports Positive Final Phase 2 Results for VT-1953; Plans to Advance Into Pivotal Study For FDA Approval
December 9, 2025
·
6 min read
Press Releases
Vyome closes Merger Transaction, Will Trade on Nasdaq as HIND Tomorrow
August 15, 2025
·
3 min read
Press Releases
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
August 8, 2025
·
3 min read
Press Releases
Vyome Announces New Board of Directors with Deep MIT and AI Ties
August 13, 2025
·
5 min read
Press Releases
Vyome Signs MoU with Embryyo, India’s Leading Medical Device Innovation Studio
August 21, 2025
·
4 min read
Press Releases
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
August 14, 2025
·
3 min read
Press Releases
Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity
September 18, 2025
·
6 min read
Press Releases
Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity
September 5, 2025
·
6 min read
1 of 4
Next
